Riccardo Robbiani

Riccardo Robbiani has a diverse work experience in the pharmaceutical and biotech industry. Riccardo is currently working as the Director of Regulatory Affairs & Market Access Switzerland at Stemline Therapeutics. Prior to this, they held the position of Lead Pricing & Reimbursement at Bristol Myers Squibb from May 2020 to December 2022.

Before joining Bristol Myers Squibb, Riccardo worked at Celgene for several years. Riccardo served as the Director of Regulatory Affairs & Fachtechnisch verantwortliche Person (RP) from April 2019 to May 2020. Prior to this role, they worked as an Associate Director, Senior Manager, and Manager of Regulatory Affairs at Celgene from 2013 to 2019.

Riccardo also gained experience at Sandoz, where they worked as a Regulatory Affairs Manager from December 2011 to August 2013. Riccardo started their career at Glycovaxyn AG, where they held positions as a Regulatory Affairs Associate and Research Associate from 2007 to 2011. So, overall, Riccardo has a strong background in regulatory affairs and market access in the pharmaceutical industry.

From 2001 to 2007, Riccardo Robbiani attended ETH Zürich, where they pursued a Master of Science (MS) degree in Microbiology and Immunology.